NCT03351439View on ClinicalTrials.gov

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Hip Pain Chronic
Interventions
DRUG

Zopiclone

Group 2 - Zopiclone 7.5 mg orally, nightly for 7 days

DRUG

Gabapentin

Group 3 - Gabapentin 600 mg orally, 1 hour pre-operatively and 600 mg orally, 8 hours post-operatively

DRUG

Celebrex

Group 4 - Celebrex 400 mg PO, 1 hour pre-operatively

DRUG

Percocet

Standard of Care

DRUG

Naprosyn

Standard of Care

Trial Locations (1)

N6A 3K7

Fowler Kennedy Sport Medicine Clinic, London

All Listed Sponsors
lead

Western University, Canada

OTHER

NCT03351439 - Efficacy of Multimodal Analgesia Following Hip Arthroscopy | Biotech Hunter | Biotech Hunter